Patent Issued for Free PSA antibodies as diagnostics, prognostics and therapeutics for prostate cancer (USPTO 11446400)

Source :: Cancer Weekly. October 11, 2022, 1130
Publication Year :: 2022
Abstract: 2022 OCT 11 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Evans, Michael (New [...]

Subjects :: Denosumab -- Reports
Prostate cancer -- Reports
Biological products -- Reports -- Intellectual property
Homeopathy -- Materia medica and therapeutics
Ipilimumab -- Reports
Therapeutics -- Reports -- Intellectual property
Business
Health
Health care industry

Tools